No recent analyst price targets found for SGIOF.
Latest News for SGIOF
New England Journal of Medicine Publishes Shionogi Study Demonstrating Ensitrelvir Prevents COVID-19 Following Exposure
OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced that results from its global, double-blind, randomized, placebo-controlled Phase 3 study, SCORPIO-PEP, were published in the New England Journal of Medicine. A five-day course of ensitrelvir significantly reduced the risk of symptomatic COVID-19 by 67% in…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SGIOF.
Senate Trading
No Senate trades found for SGIOF.
U.S. House Trading
No House trades found for SGIOF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.